Sewoon Medical Co. Ltd (100700) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sewoon Medical Co. Ltd (100700) has a cash flow conversion efficiency ratio of 0.019x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.99 Billion ≈ $2.03 Million USD) by net assets (₩156.24 Billion ≈ $105.88 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sewoon Medical Co. Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Sewoon Medical Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Sewoon Medical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Sewoon Medical Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sewoon Medical Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HNA Technology Co Ltd B
SHG:900938
|
0.011x |
|
Invesco High Income Trust II
NYSE:VLT
|
0.019x |
|
Nahar Poly Films Limited
NSE:NAHARPOLY
|
0.071x |
|
Vow ASA
OL:VOW
|
0.300x |
|
Sangsangin Investment & Securities Co Ltd
KO:001290
|
0.018x |
|
Doganlar Mobilya Grubu Imalat Sanayi ve Ticaret AS
IS:DGNMO
|
0.184x |
|
Hindustan Media Ventures Limited
NSE:HMVL
|
0.012x |
|
Focus Lighting and Fixtures Limited
NSE:FOCUS
|
0.153x |
Annual Cash Flow Conversion Efficiency for Sewoon Medical Co. Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Sewoon Medical Co. Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Sewoon Medical Co. Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩154.40 Billion ≈ $104.64 Million |
₩17.77 Billion ≈ $12.04 Million |
0.115x | +27.56% |
| 2024-12-31 | ₩146.12 Billion ≈ $99.02 Million |
₩13.19 Billion ≈ $8.94 Million |
0.090x | -46.16% |
| 2023-12-31 | ₩137.69 Billion ≈ $93.31 Million |
₩23.08 Billion ≈ $15.64 Million |
0.168x | +122.18% |
| 2022-12-31 | ₩123.01 Billion ≈ $83.36 Million |
₩9.28 Billion ≈ $6.29 Million |
0.075x | -59.90% |
| 2021-12-31 | ₩114.13 Billion ≈ $77.35 Million |
₩21.47 Billion ≈ $14.55 Million |
0.188x | -0.36% |
| 2020-12-31 | ₩101.98 Billion ≈ $69.11 Million |
₩19.25 Billion ≈ $13.05 Million |
0.189x | +33.34% |
| 2019-12-31 | ₩95.22 Billion ≈ $64.53 Million |
₩13.48 Billion ≈ $9.14 Million |
0.142x | +0.25% |
| 2018-12-31 | ₩86.35 Billion ≈ $58.52 Million |
₩12.19 Billion ≈ $8.26 Million |
0.141x | +33.38% |
| 2017-12-31 | ₩77.72 Billion ≈ $52.67 Million |
₩8.23 Billion ≈ $5.58 Million |
0.106x | +21.89% |
| 2016-12-31 | ₩73.09 Billion ≈ $49.53 Million |
₩6.35 Billion ≈ $4.30 Million |
0.087x | +56.05% |
| 2015-12-31 | ₩65.61 Billion ≈ $44.47 Million |
₩3.65 Billion ≈ $2.48 Million |
0.056x | -57.37% |
| 2014-12-31 | ₩64.35 Billion ≈ $43.61 Million |
₩8.40 Billion ≈ $5.69 Million |
0.131x | -20.28% |
| 2013-12-31 | ₩58.72 Billion ≈ $39.80 Million |
₩9.62 Billion ≈ $6.52 Million |
0.164x | +16.78% |
| 2012-12-31 | ₩51.25 Billion ≈ $34.73 Million |
₩7.19 Billion ≈ $4.87 Million |
0.140x | +26.92% |
| 2011-12-31 | ₩46.71 Billion ≈ $31.65 Million |
₩5.16 Billion ≈ $3.50 Million |
0.111x | -- |
About Sewoon Medical Co. Ltd
Sewoon Medical Co., Ltd. engages in the research and development, manufacture, and sale of medical products. Its products include wound drainage systems, urinary catheters and tubes, drainage catheters and tubes, respiratory and tracheal tubes, infusion catheters and tubes, and wound care products. The company also offers unigel, thermosens, epistim, bonastent, and other products. Sewoon Medical … Read more